Tolebrutinib shows promise for treating non-relapsing secondary progressive multiple sclerosis

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, demonstrated a 31%…

Continue ReadingTolebrutinib shows promise for treating non-relapsing secondary progressive multiple sclerosis

Food-as-medicine could save billions in healthcare costs—here’s what’s standing in its way

Researchers review how Food-as-Medicine (FAM) interventions can improve health, reduce healthcare costs, and reshape food production systems. They emphasize the urgent need for clinical validation before scaling individualized nutrition solutions.

Continue ReadingFood-as-medicine could save billions in healthcare costs—here’s what’s standing in its way